share_log

CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Treco Douglas A

SEC announcement ·  Jun 1 04:21
Summary by Futu AI
Douglas A. Treco, associated with CRISPR Therapeutics AG [CRSP], was involved in a transaction on May 30, 2024. The specific details regarding the nature of the transaction, such as the action type, status, number of shares involved, transaction price, and the resulting number of shares held after the action, have not been disclosed. As this information is crucial for investors, further updates are anticipated to provide a clearer picture of the transaction's impact on CRISPR Therapeutics' stock.
Douglas A. Treco, associated with CRISPR Therapeutics AG [CRSP], was involved in a transaction on May 30, 2024. The specific details regarding the nature of the transaction, such as the action type, status, number of shares involved, transaction price, and the resulting number of shares held after the action, have not been disclosed. As this information is crucial for investors, further updates are anticipated to provide a clearer picture of the transaction's impact on CRISPR Therapeutics' stock.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.